Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics (NASDAQ:NTLA) announced on December 1, 2025 that it granted inducement equity awards to three new employees under its 2024 Inducement Plan as material inducements to employment.

Rhea-AI Summary

Intellia Therapeutics (NASDAQ:NTLA) announced on December 1, 2025 that it granted inducement equity awards to three new employees under its 2024 Inducement Plan as material inducements to employment.

The awards are time-based restricted stock units totaling 12,600 shares, vesting in thirds on December 1, 2026, 2027, and 2028, and are subject to continued service through each vesting date. The grants were approved by the compensation committee and were made outside the company’s shareholder-approved equity incentive plans pursuant to Nasdaq Listing Rule 5635(c)(4).

Argus Dec 8 session

-1.77% close to close Open Argus

Details

News Market Reaction – NTLA

On Dec 8, the first trading day after this news, NTLA closed 1.77% below the previous close.

Data tracked by StockTitan Argus for the Dec 8 session.

Market Context

This announcement details a modest equity-based hiring tool: 12,600 time‑based RSUs granted to three...

Analysis

This announcement details a modest equity-based hiring tool: 12,600 time‑based RSUs granted to three new employees under the 2024 Inducement Plan, vesting annually from 2026 to 2028 under Nasdaq Listing Rule 5635(c)(4). Relative to prior catalysts—such as MAGNITUDE safety events and Phase 1/2 data for nex‑z and lonvo‑z—this is a routine governance item. Investors may monitor future clinical updates and any changes in capital structure for more material drivers.

Key Figures

Inducement RSUs granted: 12,600 shares New employees: 3 employees First vesting date: Dec 1, 2026 +3 more

Inducement RSUs granted

12,600 shares

Aggregate time-based RSUs granted to three new employees on Dec 1, 2025

New employees

3 employees

Recipients of inducement equity awards under 2024 Inducement Plan

First vesting date

Dec 1, 2026

One-third of RSUs vest on this date, subject to continued service

Second vesting date

Dec 1, 2027

Second one-third of RSUs vest on this date

Final vesting date

Dec 1, 2028

Final one-third of RSUs vest on this date

Inducement plan year

2024

Year of Intellia’s Inducement Plan used for these grants

Historical Context

5 past events · Latest: Nov 10

5 events

1. Nov 10

   Clinical data update

   24h Move

   +2.2%

   Longer-term Phase 1 ATTR-CM data for nex-z with sustained TTR reduction.

2. Nov 08

   Clinical data update

   24h Move

   +2.2%

   Pooled Phase 1/2 HAE data for lonvo-z showing high attack-free rates.

3. Nov 06

   Earnings and pipeline

   24h Move

   -9.2%

   Q3 2025 results plus disclosure of FDA clinical hold on Phase 3 nex-z trials.

4. Oct 27

   Safety trial pause

   24h Move

   -42.2%

   Temporary pause of MAGNITUDE trials after Grade 4 liver event and bilirubin rise.

5. Oct 03

   Inducement grants

   24h Move

   +2.9%

   Inducement RSU grants to six new employees under 2024 Inducement Plan.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

restricted stock units, RSUs, Nasdaq Listing Rule 5635(c)(4), equity incentive plans, +1 more

5 terms

restricted stock units financial

"The inducement grants consisted of time-based restricted stock units (“RSUs”)"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"time-based restricted stock units (“RSUs”) for an aggregate of 12,600 shares"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Nasdaq Listing Rule 5635(c)(4) regulatory

"as a material inducement to entering into employment ... in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

equity incentive plans financial

"awards were granted outside of Intellia’s stockholder-approved equity incentive plans"

Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.

inducement grants financial

"it awarded inducement grants to three new employees under Intellia’s 2024 Inducement Plan"

Inducement grants are special awards of shares or stock options given to new employees to encourage them to join a company or accept a new role. They act like a welcome bonus, providing an extra incentive to attract talent. For investors, these grants can impact a company's costs and share structure, influencing the value of their investments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on December 1, 2025, it awarded inducement grants to three new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment.

The inducement grants consisted of time-based restricted stock units (“RSUs”) for an aggregate of 12,600 shares of Intellia’s common stock, with one-third of such RSUs vesting on December 1, 2026, 2027 and 2028.

All equity vesting is subject to each employee’s continued service as an employee of, or other service provider to, Intellia through the applicable vesting dates.

All of the above-described awards were granted outside of Intellia’s stockholder-approved equity incentive plans pursuant to Intellia’s 2024 Inducement Plan, which was adopted by the board of directors in June 2024. These awards were approved by Intellia’s compensation committee as a material inducement to entering into employment with Intellia in accordance with Nasdaq Listing Rule 5635(c)(4).

About Intellia Therapeutics

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on leveraging gene editing technology to develop novel, first-in-class medicines that address important unmet medical needs and advance the treatment paradigm for patients. Intellia’s deep scientific, technical and clinical development experience, along with its people, is helping set the standard for a new class of medicine. To harness the full potential of gene editing, Intellia continues to expand the capabilities of its CRISPR-based platform with novel editing and delivery technologies. Learn more at intelliatx.com and follow us @intelliatx.

Intellia Contacts:

Investors:
Jason Fredette
Vice President, Investor Relations and Corporate Communications
Intellia Therapeutics, Inc.
jason.fredette@intelliatx.com

Media:
Matt Crenson
Ten Bridge Communications
media@intelliatx.com
mcrenson@tenbridgecommunications.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Intellia (NTLA) announce on December 1, 2025 regarding inducement grants?

Intellia granted time-based RSUs totaling 12,600 shares to three new employees as inducements to employment.

When do the Intellia (NTLA) inducement RSUs vest?

The RSUs vest in equal thirds on December 1, 2026, 2027, and 2028, subject to continued service.

Why were the Intellia (NTLA) awards granted outside existing equity plans?

The awards were issued under Intellia’s 2024 Inducement Plan and approved as material inducements in accordance with Nasdaq Listing Rule 5635(c)(4).

How many employees received inducement awards from Intellia (NTLA)?

Three new employees received the inducement restricted stock unit awards.

Do Intellia (NTLA) inducement RSUs carry additional service conditions?

Yes; all equity vesting is conditioned on each recipient’s continued service as an employee or service provider through each vesting date.